COST-EFFECTIVENESS OF RIVAROXABAN FOR THE TREATMENT OF PULMONARY EMBOLISM IN CANADA

被引：1
|
作者：
Levac, B. [1 ]
Marrie, J. [1 ]
Chin, W. [2 ]
Hassan, F. [3 ]
Bamber, L. [4 ]
McLeod, E. J. [3 ]
机构：
[1] Bayer Inc, Toronto, ON, Canada
[2] ILEX Consulting Inc, Toronto, ON, Canada
[3] IMS Hlth, London, England
[4] Bayer Healthcare, Leverkusen, Germany
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.684
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV90
引用
收藏
页码：A117 / A118
页数：2
相关论文
共 50 条
  • [31] Spiral CT angiography for suspected pulmonary embolism: A cost-effectiveness analysis
    vanErkel, AR
    vanRossum, AB
    Bloem, JL
    Klevit, J
    Pattynama, PMT
    RADIOLOGY, 1996, 201 (01) : 29 - 36
  • [32] Cost-effectiveness of non-invasive diagnostic strategies in pulmonary embolism
    Lijmer, JG
    van den Hout, W
    de Monye, W
    Sanson, BJ
    Prins, M
    Huisman, M
    Pattynama, P
    Büller, H
    THROMBOSIS AND HAEMOSTASIS, 1999, : 173 - 173
  • [33] Influence of age on the cost-effectiveness of diagnostic strategies for suspected pulmonary embolism
    Righini, M.
    Nendaz, M.
    Le Gal, G.
    Bounameaux, H.
    Perrier, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (09) : 1869 - 1877
  • [34] Cost-effectiveness of ABI Screening and Rivaroxaban in CHD
    Graewert, Stephanie
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2022, 27 (03): : 115 - 115
  • [35] Effectiveness of Rivaroxaban among Patients Diagnosed With Pulmonary Embolism
    Wang, Li
    Baser, Onur
    Wells, Phil
    Peacock, W. F.
    Coleman, Craig
    Fermann, Gregory J.
    Schein, Jeff
    Crivera, Concetta
    CIRCULATION, 2016, 134
  • [36] CT pulmonary angiography for acute pulmonary embolism: Cost-effectiveness analysis and review of the literature
    Quiroz, R
    Schoepf, UJ
    SEMINARS IN ROENTGENOLOGY, 2005, 40 (01) : 20 - 24
  • [37] COST-EFFECTIVENESS ANALYSIS OF BEMIPARIN USED AS ACUTE TREATMENT FOR DEEP VENOUS THROMBOSIS WITHOUT PULMONARY EMBOLISM
    Aguirre, A.
    Carlos, F.
    Naranjo, M.
    Fernandez, C.
    VALUE IN HEALTH, 2015, 18 (07) : A392 - A392
  • [38] Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
    Buller, Harry R.
    Prins, Martin H.
    Lensing, Anthonie W. A.
    Decousus, Herve
    Jacobson, Barry F.
    Minar, Erich
    Chlumsky, Jaromir
    Verhamme, Peter
    Wells, Phil
    Agnelli, Giancarlo
    Cohen, Alexander
    Berkowitz, Scott D.
    Bounameaux, Henri
    Davidson, Bruce L.
    Misselwitz, Frank
    Gallus, Alex S.
    Raskob, Gary E.
    Schellong, Sebastian
    Segers, Annelise
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (14): : 1287 - 1297
  • [39] Oral rivaroxaban for the treatment of symptomatic pulmonary embolism
    Garcia-Bragado Dalmau, F.
    REVISTA CLINICA ESPANOLA, 2013, 213 (05): : 256 - 257
  • [40] COST-EFFECTIVENESS ANALYSIS OF APIXABAN AND RIVAROXABAN FOR TREATMENT OF ACUTE VENOUS THROMBOEMBOLISM IN CHINA
    Gu, X.
    Wu, B.
    VALUE IN HEALTH, 2017, 20 (09) : A618 - A618
12345